Corbus Pharmaceuticals Rare Disease Therapies Pipeline

Corbus Pharmaceuticals develops breakthrough therapies for rare inflammatory and fibrotic diseases, focusing on underserved conditions where 95% lack approved treatments. The company operates a specialized business model combining drug acquisition, pipeline development, and expert-led commercialization through Phase 2 expansion to market.